Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
Indian J Pharmacol
.
2009 Aug;41(4):197-8.
doi: 10.4103/0253-7613.56070.
Author
Rajiv Mahajan
1
Affiliation
1
Department of Pharmacology, AIMSR, Bhatinda, India. E-mail: drrajivmahajan01@yahoo.co.in.
PMID:
20523873
PMCID:
PMC2875741
DOI:
10.4103/0253-7613.56070
No abstract available